Article info

Download PDFPDF
One-year outcome of intravitreal ziv-aflibercept therapy for non-responsive neovascular age-related macular degeneration

Authors

  • Imoro Zeba Braimah School of Medicine and Dentistry, College of Health Sciences, University of Ghana, Accra, Ghana Srimati Kanuri Santhamma Centre for Vitreo Retinal Diseases, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India PubMed articlesGoogle scholar articles
  • Komal Agarwal Srimati Kanuri Santhamma Centre for Vitreo Retinal Diseases, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India PubMed articlesGoogle scholar articles
  • Ahmad Mansour Department of Ophthalmology, American University of Beirut, Beirut, Lebanon Department of Ophthalmology, Rafic Hariri University Hospital, Beirut, Lebanon PubMed articlesGoogle scholar articles
  • Jay Chhablani Srimati Kanuri Santhamma Centre for Vitreo Retinal Diseases, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India PubMed articlesGoogle scholar articles
  • on behalf of Ziv-aflibercept Study Group
    Google scholar articles
  1. Correspondence to Dr Jay Chhablani, LV Prasad Eye Institute, Banjara Hills, Road no. 2 Hyderabad 500034, India; jay.chhablani{at}gmail.com
View Full Text

Citation

Braimah IZ, Agarwal K, Mansour A on behalf of Ziv-aflibercept Study Group, et al
One-year outcome of intravitreal ziv-aflibercept therapy for non-responsive neovascular age-related macular degeneration

Publication history

  • Received February 10, 2017
  • Revised April 24, 2017
  • Accepted April 30, 2017
  • First published June 8, 2017.
Online issue publication 
December 15, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.